Laurus Labs to acquire stake in Laurus Bio

12 Sep 2023 Evaluate

Laurus Labs has signed Share Purchase agreements with one of the Promoters and non-executive director and his family members and also with few employees/ex-employee shareholders of Laurus Bio for purchase of 37,641 equity shares through secondary purchase. With this acquisition, the shareholding of the Company in Laurus Bio will become 87.58% on fully diluted basis (including outstanding share warrants and ESOP Pool). 

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

512.45 23.40 (4.78%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.